Background: According to the latest 2016 World Health Organization data, an estimated 422 million adults are living with diabetes. The coexistence of diabetes mellitus (DM) and its cardiovascular complications is considered as metabolic syndrome (MetS). One of the major cardiometabolic risk determinants of MetS is diabetic dyslipidemia.
Aims and Objectives: The objectives of the study were to evaluate the lipid profile and its derangements in diabetic patients and predict cardiovascular risk in patients with Type 2 DM (T2DM) using Framingham risk scoring (FRS) for men and women.
Materials and Methods: FRS, a gender-specific algorithm, was used to estimate the global 10-year cardiovascular risk. The score was classified into two risk categories: High risk (if >10%) and low risk (if 10% (high risk) whereas 13 (26%) patients were having risk
The articles in Bibliomed are open access articles licensed under Creative Commons Attribution 4.0 International License (CC BY), which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.
Download PDF 
Post
